News
The pharmacy benefits landscape is undergoing a period of transformation. As rising drug costs, increased regulatory pressure ...
The president's proposed budget cuts to the NIH would eventually result in fewer drugs on the market, the U.S. Congressional ...
Varda Space Industries, based in El Segundo, makes drugs in space. But Will Bruey, Varda co-founder and chief executive, says ...
As we stride further into 2025, the pharmacy industry faces a landscape teeming with challenges and opportunities. From tackling drug price transparency to juggling implementation of artificial ...
3h
24/7 Wall St. on MSN4 High-Yield Blue-Chip Pharmaceutical Giants Offer Huge Total Return PotentialHere are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.
The pharmaceutical industry’s move toward increased U.S.-based manufacturing is changing the landscape of career ...
Act 624 of 2025 bans pharmacy benefit managers (PBMs) from holding a permit to operate a drug store in Arkansas after Jan. 1, ...
A provision to end pharma's ad tax deductibility was dropped from the One Big Beautiful Bill but still remains firmly in D.C.’s crosshairs.
In an exclusive interview with Business Today, D. Sridhar Babu, Minister for Information Technology, Industries and Commerce, ...
Britain launched a life sciences sector plan on Wednesday to a mixed response from the pharmaceutical industry, which ...
3don MSN
Empower Pharmacy, a Houston-based compounding pharmacy, has been sanctioned by the FDA and other states in the past decade.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results